Skip to main content
SpringerLink
Log in

Morphologic Investigations in Head and Neck Cancer

  • Chapter
  • First Online:
Head and Neck Cancer

  • 2492 Accesses

Abstract

Head and neck cancer (HNC) is the fifth most common cancer worldwide and is traditionally associated with high morbidity and mortality. Patients with head and neck squamous cell cancer require a careful evaluation and a multidisciplinary team approach to determine optimal management. Treatment planning depends on TNM staging, which is evaluated with physical examination, endoscopies, and cross-sectional imaging. CT and MR imaging form the main stays of cross-sectional imaging and is extensively utilized in characterizing and staging of malignant tumors involving the head and neck which is critical for the selection of appropriate therapeutic regimens. The goal of imaging in patients with HNC are to establish tumor extent and size, to assess nodal disease, for possible perineural tumor spread, to distinguish recurrent tumor from posttreatment changes, and to monitor the result and response of treatment. Cross-sectional imaging supplements and compliments the physical examination by delineating the complex anatomic and pathological changes of the neck. CT and MRI complement each other; certain conditions are better studied with one than the other. Various strengths and weaknesses of each modality should be carefully considered when selecting them for tumor assessment and follow up. Certain newer techniques, such as CT and MR perfusion, MR spectroscopy, facilitate the evaluation of functional parameters in oncologic patients, such as tissue perfusion, which can integrate the morphologic and metabolic information derived from conventional techniques and have the potential to identify the characteristics that could indicate malignant progression. Recently, functional imaging with 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) was introduced and found to be superior to conventional imaging work-ups in the evaluation of patients with head and neck malignancies. It improves the detection of occult cervical lymphatic disease, distant metastasis, and assists in localization of unknown primary carcinoma of head and neck region or a synchronous second tumor. Combined PET/CT scanners have improved anatomic localization of HNC, incorporating the anatomic accuracy of CT with functional data of 18FDG-PET. From methodological development, these morphologic investigations are making the critical transition to preclinical and clinical validating methods and eventually to widespread clinical tools.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res. 1998;18(6B):4779–86.

    PubMed  CAS  Google Scholar 

  2. American Cancer Society. Cancer facts and figures 2009, American Cancer Society surveillance research. http://www.cancer.org. Accessed 14 Jan, 2010

  3. Dammann F, Horger M, Mueller-Berg M, et al. Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. AJR Am J Roentgenol. 2005;184(4):1326–31.

    PubMed  Google Scholar 

  4. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol. 1992;158(5):961–9.

    PubMed  CAS  Google Scholar 

  5. Madison MT, Remley KB, Latchaw RE, Mitchell SL. Radiologic diagnosis and staging of head and neck squamous cell carcinoma. Radiol Clin North Am. 1994;32(1):163–81.

    PubMed  CAS  Google Scholar 

  6. Close LG, Merkel M, Vuitch MF, Reisch J, Schaefer SD. Computed tomographic evaluation of regional lymph node involvement in cancer of the oral cavity and oropharynx. Head Neck. 1989;11(4):309–17.

    PubMed  CAS  Google Scholar 

  7. Stark DD, Moss AA, Gamsu G, Clark OH, Gooding GA, Webb WR. Magnetic resonance imaging of the neck. Part II: Pathologic findings. Radiology. 1984;150(2):455–61.

    PubMed  CAS  Google Scholar 

  8. Gatenby RA, Mulhern Jr CB, Strawitz J, Moldofsky PJ. Comparison of clinical and computed tomographic staging of head and neck tumors. AJNR Am J Neuroradiol. 1985;6(3):399–401.

    PubMed  CAS  Google Scholar 

  9. Rumboldt Z, Gordon L, Bonsall R, Ackermann S. Imaging in head and neck cancer. Curr Treat Options Oncol. 2006;7(1):23–34.

    PubMed  Google Scholar 

  10. Gordin A, Golz A, Keidar Z, Daitzchman M, Bar-Shalom R, Israel O. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care. Otolaryngol Head Neck Surg. 2007;137(1):130–7.

    PubMed  Google Scholar 

  11. Wippold 2nd FJ. Head and neck imaging: the role of CT and MRI. J Magn Reson Imaging. 2007;25(3):453–65.

    PubMed  Google Scholar 

  12. Hu H, He HD, Foley WD, Fox SH. Four multidetector-row helical CT: image quality and volume coverage speed. Radiology. 2000;215(1):55–62.

    PubMed  CAS  Google Scholar 

  13. Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. Eur J Radiol. 1999;30(3):198–205.

    PubMed  CAS  Google Scholar 

  14. Faggioni L, Neri E, Bartolozzi C. CT perfusion of head and neck tumors: how we do it. AJR Am J Roentgenol. 2010;194(1):62–9.

    PubMed  Google Scholar 

  15. Gandhi D, Chepeha DB, Miller T, et al. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol. 2006;27(1):101–6.

    PubMed  CAS  Google Scholar 

  16. Zima A, Carlos R, Gandhi D, Case I, Teknos T, Mukherji SK. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol. 2007;28(2):328–34.

    PubMed  CAS  Google Scholar 

  17. Rumboldt Z, Al-Okaili R, Deveikis JP. Perfusion CT for head and neck tumors: pilot study. AJNR Am J Neuroradiol. 2005;26(5):1178–85.

    PubMed  Google Scholar 

  18. Ash L, Teknos TN, Gandhi D, Patel S, Mukherji SK. Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density. Radiology. 2009;251(2):422–8.

    PubMed  Google Scholar 

  19. Weber AL, Romo L, Hashmi S. Malignant tumors of the oral cavity and oropharynx: clinical, pathologic, and radiologic evaluation. Neuroimaging Clin N Am. 2003;13(3):443–64.

    PubMed  Google Scholar 

  20. Shah GV. MR imaging of salivary glands. Neuroimaging Clin N Am. 2004;14(4):777–808.

    PubMed  Google Scholar 

  21. Rasch C, Keus R, Pameijer FA, et al. The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1997;39(4):841–8.

    PubMed  CAS  Google Scholar 

  22. van den Brekel MW, Castelijns JA, Croll GA, et al. Magnetic resonance imaging vs palpation of cervical lymph node metastasis. Arch Otolaryngol Head Neck Surg. 1991;117(6):663–73.

    PubMed  Google Scholar 

  23. van Dijke CF, van Waes PF. Head and neck tumors. MRI versus CT: a technology assessment pilot study. Eur J Radiol. 1992;14(3):235–9.

    PubMed  Google Scholar 

  24. McCabe KJ, Rubinstein D. Advances in head and neck imaging. Otolaryngol Clin North Am. 2005;38(2):307–19. vii.

    PubMed  Google Scholar 

  25. Baba Y, Furusawa M, Murakami R, et al. Role of dynamic MRI in the evaluation of head and neck cancers treated with radiation therapy. Int J Radiat Oncol Biol Phys. 1997;37(4):783–7.

    PubMed  CAS  Google Scholar 

  26. Hudgins PA, Gussack GS. MR imaging in the management of extracranial malignant tumors of the head and neck. AJR Am J Roentgenol. 1992;159(1):161–9.

    PubMed  CAS  Google Scholar 

  27. Jabour BA, Lufkin RB, Hanafee WN. Magnetic resonance imaging of the larynx. Top Magn Reson Imaging. 1990;2(4):60–8.

    PubMed  CAS  Google Scholar 

  28. Glazer HS, Lee JK, Levitt RG, et al. Radiation fibrosis: differentiation from recurrent tumor by MR imaging. Radiology. 1985;156(3):721–6.

    PubMed  CAS  Google Scholar 

  29. Hasso AN, Brown KD. Use of gadolinium chelates in MR imaging of lesions of the extracranial head and neck. J Magn Reson Imaging. 1993;3(1):247–63.

    PubMed  CAS  Google Scholar 

  30. Lam P, Au-Yeung KM, Cheng PW, et al. Correlating MRI and histologic tumor thickness in the assessment of oral tongue cancer. AJR Am J Roentgenol. 2004;182(3):803–8.

    PubMed  Google Scholar 

  31. Curtin HD, Ishwaran H, Mancuso AA, Dalley RW, Caudry DJ, McNeil BJ. Comparison of CT and MR imaging in staging of neck metastases. Radiology. 1998;207(1):123–30.

    PubMed  CAS  Google Scholar 

  32. Yousem DM. Dashed hopes for MR imaging of the head and neck: the power of the needle. Radiology. 1992;184(1):25–6.

    PubMed  CAS  Google Scholar 

  33. Shah GV, Wesolowski JR, Ansari SA, Mukherji SK. New directions in head and neck imaging. J Surg Oncol. 2008;97(8):644–8.

    PubMed  Google Scholar 

  34. Chenevert TL, Meyer CR, Moffat BA, et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging. 2002;1(4):336–43.

    PubMed  Google Scholar 

  35. Ross BD, Moffat BA, Lawrence TS, et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther. 2003;2(6):581–7.

    PubMed  CAS  Google Scholar 

  36. Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol. 2006;16(7):1468–77.

    PubMed  Google Scholar 

  37. Sumi M, Sakihama N, Sumi T, et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol. 2003;24(8):1627–34.

    PubMed  Google Scholar 

  38. Hermans R, Vandecaveye V. Diffusion-weighted MRI in head and neck cancer. Cancer Imaging. 2007;7:126–7.

    PubMed  Google Scholar 

  39. Vandecaveye V, De Keyzer F, Vander Poorten V, et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology. 2009;251(1):134–46.

    PubMed  Google Scholar 

  40. Schaefer PW, Ozsunar Y, He J, et al. Assessing tissue viability with MR diffusion and perfusion imaging. AJNR Am J Neuroradiol. 2003;24(3):436–43.

    PubMed  Google Scholar 

  41. Bisdas S, Baghi M, Smolarz A, et al. Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies. Invest Radiol. 2007;42(3):172–9.

    PubMed  Google Scholar 

  42. Schmitt P, Kotas M, Tobermann A, Haase A, Flentje M. Quantitative tissue perfusion measurements in head and neck carcinoma patients before and during radiation therapy with a non-invasive MR imaging spin-labeling technique. Radiother Oncol. 2003;67(1):27–34.

    PubMed  Google Scholar 

  43. Niemi PT, Komu ME, Koskinen SK. Tissue specificity of low-field-strength magnetization transfer contrast imaging. J Magn Reson Imaging. 1992;2(2):197–201.

    PubMed  CAS  Google Scholar 

  44. Gillams AR, Fuleihan N, Grillone G, Carter AP. Magnetization transfer contrast MR in lesions of the head and neck. AJNR Am J Neuroradiol. 1996;17(2):355–60.

    PubMed  CAS  Google Scholar 

  45. Shah GV, Fischbein NJ, Patel R, Mukherji SK. Newer MR imaging techniques for head and neck. Magn Reson Imaging Clin N Am. 2003;11(3):449–69. vi.

    PubMed  Google Scholar 

  46. Shah GV, Gandhi D, Mukherji SK. Magnetic resonance spectroscopy of head and neck neoplasms. Top Magn Reson Imaging. 2004;15(2):87–94.

    PubMed  Google Scholar 

  47. Mukherji SK, Schiro S, Castillo M, Kwock L, Muller KE, Blackstock W. Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. AJNR Am J Neuroradiol. 1997;18(6):1057–72.

    PubMed  CAS  Google Scholar 

  48. Mukherji SK, Schiro S, Castillo M, et al. Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. AJNR Am J Neuroradiol. 1996;17(8):1485–90.

    PubMed  CAS  Google Scholar 

  49. Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol. 1996;17(1):1–15.

    PubMed  CAS  Google Scholar 

  50. King AD, Yeung DK, Ahuja AT, Leung SF, Tse GM, van Hasselt AC. In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma. AJNR Am J Neuroradiol. 2004;25(3):484–90.

    PubMed  Google Scholar 

  51. El-Sayed S, Bezabeh T, Odlum O, et al. An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head Neck. 2002;24(8):766–72.

    PubMed  Google Scholar 

  52. Bezabeh T, Odlum O, Nason R, et al. Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy. AJNR Am J Neuroradiol. 2005;26(8):2108–13.

    PubMed  Google Scholar 

  53. Nordsmark M, Bentzen SM, Rudat V, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol. 2005;77(1):18–24.

    PubMed  Google Scholar 

  54. Le QT, Giaccia AJ. Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer. Clin Cancer Res. 2003;9(12):4287–95.

    PubMed  CAS  Google Scholar 

  55. Rudat V, Vanselow B, Wollensack P, et al. Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer. Radiother Oncol. 2000;57(1):31–7.

    PubMed  CAS  Google Scholar 

  56. Star-Lack JM, Adalsteinsson E, Adam MF, et al. In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. AJNR Am J Neuroradiol. 2000;21(1):183–93.

    PubMed  CAS  Google Scholar 

  57. Le QT, Koong A, Lieskovsky YY, et al. In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2008;71(4):1151–7.

    PubMed  Google Scholar 

  58. Schmid DT, Stoeckli SJ, Bandhauer F, et al. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope. 2003;113(5):888–91.

    PubMed  Google Scholar 

  59. Stokkel MP, ten Broek FW, Hordijk GJ, Koole R, van Rijk PP. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. Ann Surg. 2000;231(2):229–34.

    PubMed  CAS  Google Scholar 

  60. Paulus P, Sambon A, Vivegnis D, et al. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope. 1998;108(10):1578–83.

    PubMed  CAS  Google Scholar 

  61. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope. 1992;102(3):281–8.

    PubMed  CAS  Google Scholar 

  62. Hannah A, Scott AM, Tochon-Danguy H, et al. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg. 2002;236(2):208–17.

    PubMed  Google Scholar 

  63. Jungehulsing M, Scheidhauer K, Damm M, et al. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg. 2000;123(3):294–301.

    PubMed  CAS  Google Scholar 

  64. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med. 1995;36(10):1747–57.

    PubMed  CAS  Google Scholar 

  65. Hafidh MA, Lacy PD, Hughes JP, Duffy G, Timon CV. Evaluation of the impact of addition of PET to CT and MR scanning in the staging of patients with head and neck carcinomas. Eur Arch Otorhinolaryngol. 2006;263(9):853–9.

    PubMed  Google Scholar 

  66. Keyes Jr JW, Watson Jr NE, Williams 3rd DW, Greven KM, McGuirt WF. FDG PET in head and neck cancer. AJR Am J Roentgenol. 1997;169(6):1663–9.

    PubMed  Google Scholar 

  67. Macapinlac HA, Yeung HW, Larson SM. Defining the role of FDG PET in head and neck cancer. Clin Positron Imaging. 1999;2(6):311–6.

    PubMed  Google Scholar 

  68. Roh JL, Yeo NK, Kim JS, et al. Utility of 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral Oncol. 2007;43(9):887–93.

    PubMed  Google Scholar 

  69. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med. 2001;42(5 Suppl):1S–93.

    PubMed  CAS  Google Scholar 

  70. Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998;25(9):1255–60.

    PubMed  CAS  Google Scholar 

  71. Braams JW, Pruim J, Freling NJ, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med. 1995;36(2):211–6.

    PubMed  CAS  Google Scholar 

  72. Lowe VJ, Boyd JH, Dunphy FR, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol. 2000;18(3):651–8.

    PubMed  CAS  Google Scholar 

  73. Wong RJ, Lin DT, Schoder H, et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol. 2002;20(20):4199–208.

    PubMed  CAS  Google Scholar 

  74. Mukherji SK, Bradford CR. Controversies: is there a role for positron-emission tomographic CT in the initial staging of head and neck squamous cell carcinoma? AJNR Am J Neuroradiol. 2006;27(2):243–5.

    PubMed  Google Scholar 

  75. Gil Z, Even-Sapir E, Margalit N, Fliss DM. Integrated PET/CT system for staging and surveillance of skull base tumors. Head Neck. 2007;29(6):537–45.

    PubMed  Google Scholar 

  76. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41(8):1369–79.

    PubMed  CAS  Google Scholar 

  77. Townsend DW, Carney JP, Yap JT, Hall NC. PET/CT today and tomorrow. J Nucl Med. 2004;45 Suppl 1:4S–14.

    PubMed  Google Scholar 

  78. Ha PK, Hdeib A, Goldenberg D, et al. The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006;132(1):12–6.

    PubMed  Google Scholar 

  79. Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology. 2002;225(2):575–81.

    PubMed  Google Scholar 

  80. von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology. 2006;238(2):405–22.

    Google Scholar 

  81. Branstetter BF, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology. 2005;235(2):580–6.

    PubMed  Google Scholar 

  82. Antoch G, Saoudi N, Kuehl H, et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol. 2004;22(21):4357–68.

    PubMed  Google Scholar 

  83. Schwartz DL, Ford E, Rajendran J, et al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;61(1):129–36.

    PubMed  Google Scholar 

  84. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231(1):65–72.

    PubMed  Google Scholar 

  85. Syed R, Bomanji JB, Nagabhushan N, et al. Impact of combined (18)F-FDG PET/CT in head and neck tumours. Br J Cancer. 2005;92(6):1046–50.

    PubMed  CAS  Google Scholar 

  86. Fakhry N, Lussato D, Jacob T, Giorgi R, Giovanni A, Zanaret M. Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications. Eur Arch Otorhinolaryngol. 2007;264(5):531–8.

    PubMed  Google Scholar 

  87. Keidar Z, Haim N, Guralnik L, et al. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med. 2004;45(10):1640–6.

    PubMed  Google Scholar 

  88. Kamel IR, Cohade C, Neyman E, Fishman EK, Wahl RL. Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdom Imaging. 2004;29(6):663–8.

    PubMed  CAS  Google Scholar 

  89. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348(25):2500–7.

    PubMed  Google Scholar 

  90. Zimmer LA, Branstetter BF, Nayak JV, Johnson JT. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck. Laryngoscope. 2005;115(11):2029–34.

    PubMed  Google Scholar 

  91. Reinartz P, Wieres FJ, Schneider W, Schur A, Buell U. Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT? Eur J Nucl Med Mol Imaging. 2004;31(11):1456–61.

    PubMed  Google Scholar 

  92. Mukherji SK, Drane WE, Mancuso AA, Parsons JT, Mendenhall WM, Stringer S. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-d-glucose SPECT. Radiology. 1996;199(3):761–6.

    PubMed  CAS  Google Scholar 

  93. Kole AC, Nieweg OE, Pruim J, et al. Detection of unknown occult primary tumors using positron emission tomography. Cancer. 1998;82(6):1160–6.

    PubMed  CAS  Google Scholar 

  94. Sheikholeslam-zadeh R, Choufani G, Goldman S, Hassid S. Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers. Acta Otorhinolaryngol Belg. 2002;56(1):77–82.

    PubMed  CAS  Google Scholar 

  95. Gutzeit A, Antoch G, Kuhl H, et al. Unknown primary tumors: detection with dual-modality PET/CT-initial experience. Radiology. 2005;234(1):227–34.

    PubMed  Google Scholar 

  96. Lowe VJ, Dunphy FR, Varvares M, et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck. 1997;19(8):666–74.

    PubMed  CAS  Google Scholar 

  97. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004;231(2):305–32.

    PubMed  Google Scholar 

  98. Kim MR, Roh JL, Kim JS, et al. Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx. Eur J Surg Oncol. 2007;33(5):633–8.

    PubMed  CAS  Google Scholar 

  99. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer. 1994;73(12):3047–58.

    PubMed  CAS  Google Scholar 

  100. Wong WL, Chevretton EB, McGurk M, et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol Allied Sci. 1997;22(3):209–14.

    PubMed  CAS  Google Scholar 

  101. Blodgett TM, Fukui MB, Snyderman CH, et al. Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake. Radiographics. 2005;25(4):897–912.

    PubMed  Google Scholar 

  102. Popperl G, Lang S, Dagdelen O, et al. Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer. Rofo. 2002;174(6):714–20.

    PubMed  CAS  Google Scholar 

  103. Mukherji SK, Isaacs DL, Creager A, Shockley W, Weissler M, Armao D. CT detection of mandibular invasion by squamous cell carcinoma of the oral cavity. AJR Am J Roentgenol. 2001;177(1):237–43.

    PubMed  CAS  Google Scholar 

  104. Bolzoni A, Cappiello J, Piazza C, et al. Diagnostic accuracy of magnetic resonance imaging in the assessment of mandibular involvement in oral-oropharyngeal squamous cell carcinoma: a prospective study. Arch Otolaryngol Head Neck Surg. 2004;130(7):837–43.

    PubMed  Google Scholar 

  105. Weissman JL, Carrau RL. “Puffed-cheek” CT improves evaluation of the oral cavity. AJNR Am J Neuroradiol. 2001;22(4):741–4.

    PubMed  CAS  Google Scholar 

  106. Chong VF, Mukherji SK, Ng SH, et al. Nasopharyngeal carcinoma: review of how imaging affects staging. J Comput Assist Tomogr. 1999;23(6):984–93.

    PubMed  CAS  Google Scholar 

  107. Sakata K, Hareyama M, Tamakawa M, et al. Prognostic factors of nasopharynx tumors investigated by MR imaging and the value of MR imaging in the newly published TNM staging. Int J Radiat Oncol Biol Phys. 1999;43(2):273–8.

    PubMed  CAS  Google Scholar 

  108. Rumboldt Z, Castillo M, Smith JK. The palatovaginal canal: can it be identified on routine CT and MR imaging? AJR Am J Roentgenol. 2002;179(1):267–72.

    PubMed  Google Scholar 

  109. Curtin HD. Detection of perineural spread: fat suppression versus no fat suppression. AJNR Am J Neuroradiol. 2004;25(1):1–3.

    PubMed  Google Scholar 

  110. Ginsberg LE. MR imaging of perineural tumor spread. Neuroimaging Clin N Am. 2004;14(4):663–77.

    PubMed  Google Scholar 

  111. Becker M, Zbaren P, Delavelle J, et al. Neoplastic invasion of the laryngeal cartilage: reassessment of criteria for diagnosis at CT. Radiology. 1997;203(2):521–32.

    PubMed  CAS  Google Scholar 

  112. Zbaren P, Becker M, Lang H. Pretherapeutic staging of laryngeal carcinoma. Clinical findings, computed tomography, and magnetic resonance imaging compared with histopathology. Cancer. 1996;77(7):1263–73.

    PubMed  CAS  Google Scholar 

  113. Habermann CR, Gossrau P, Graessner J, et al. Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors? Rofo. 2005;177(7):940–5.

    PubMed  CAS  Google Scholar 

  114. Divi V, Fatt MA, Teknos TN, Mukherji SK. Use of cross-sectional imaging in predicting surgical location of parotid neoplasms. J Comput Assist Tomogr. 2005;29(3):315–9.

    PubMed  Google Scholar 

  115. Schmalfuss IM, Tart RP, Mukherji S, Mancuso AA. Perineural tumor spread along the auriculotemporal nerve. AJNR Am J Neuroradiol. 2002;23(2):303–11.

    PubMed  Google Scholar 

  116. Ng SH, Yen TC, Liao CT, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med. 2005;46(7):1136–43.

    PubMed  Google Scholar 

  117. Williams 3rd DW. An imager’s guide to normal neck anatomy. Semin Ultrasound CT MR. 1997;18(3):157–81.

    PubMed  Google Scholar 

  118. Byers RM, Wolf PF, Ballantyne AJ. Rationale for elective modified neck dissection. Head Neck Surg. 1988;10(3):160–7.

    PubMed  CAS  Google Scholar 

  119. Giacomarra V, Tirelli G, Papanikolla L, Bussani R. Predictive factors of nodal metastases in oral cavity and oropharynx carcinomas. Laryngoscope. 1999;109(5):795–9.

    PubMed  CAS  Google Scholar 

  120. Yousem DM, Som PM, Hackney DB, Schwaibold F, Hendrix RA. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology. 1992;182(3):753–9.

    PubMed  CAS  Google Scholar 

  121. Takashima S, Noguchi Y, Takeuchi N, et al. Head and neck carcinoma: detection of extraorgan spread with MR imaging and CT. Eur J Radiol. 1992;14(3):228–34.

    PubMed  CAS  Google Scholar 

  122. Jabour BA, Choi Y, Hoh CK, et al. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology. 1993;186(1):27–35.

    PubMed  CAS  Google Scholar 

  123. Benchaou M, Lehmann W, Slosman DO, et al. The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngol. 1996;116(2):332–5.

    PubMed  CAS  Google Scholar 

  124. McGuirt WF, Williams 3rd DW, Keyes Jr JW, et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope. 1995;105(4 Pt 1):373–5.

    PubMed  CAS  Google Scholar 

  125. Fukui MB, Blodgett TM, Snyderman CH, et al. Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging. Radiographics. 2005;25(4):913–30.

    PubMed  Google Scholar 

  126. Hyde NC, Prvulovich E, Newman L, Waddington WA, Visvikis D, Ell P. A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol. 2003;39(4):350–60.

    PubMed  CAS  Google Scholar 

  127. Stoeckli SJ, Steinert H, Pfaltz M, Schmid S. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck. 2002;24(4):345–9.

    PubMed  Google Scholar 

  128. van den Brekel MW. Lymph node metastases: CT and MRI. Eur J Radiol. 2000;33(3):230–8.

    PubMed  Google Scholar 

  129. Murakami R, Uozumi H, Hirai T, et al. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2007;68(2):377–82.

    PubMed  Google Scholar 

  130. Schoder H, Erdi YE, Larson SM, Yeung HW. PET/CT: a new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging. 2003;30(10):1419–37.

    PubMed  Google Scholar 

  131. Basu D, Siegel BA, McDonald DJ, Nussenbaum B. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18. Arch Otolaryngol Head Neck Surg. 2007;133(8):801–5.

    PubMed  Google Scholar 

  132. de Bree R, Deurloo EE, Snow GB, Leemans CR. Screening for distant metastases in patients with head and neck cancer. Laryngoscope. 2000;110(3 Pt 1):397–401.

    PubMed  Google Scholar 

  133. Brouwer J, Bree R, Hoekstra OS, Langendijk JA, Castelijns JA, Leemans CR. Screening for distant metastases in patients with head and neck cancer: what is the current clinical practice? Clin Otolaryngol. 2005;30(5):438–43.

    PubMed  CAS  Google Scholar 

  134. Preciado DA, Sebring LA, Adams GL. Treatment of patients with spinal metastases from head and neck neoplasms. Arch Otolaryngol Head Neck Surg. 2002;128(5):539–43.

    PubMed  Google Scholar 

  135. Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1977;40(1):145–51.

    PubMed  CAS  Google Scholar 

  136. Calhoun KH, Fulmer P, Weiss R, Hokanson JA. Distant metastases from head and neck squamous cell carcinomas. Laryngoscope. 1994;104(10):1199–205.

    PubMed  CAS  Google Scholar 

  137. Al-Othman MO, Morris CG, Hinerman RW, Amdur RJ, Mendenhall WM. Distant metastases after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck. 2003;25(8):629–33.

    PubMed  Google Scholar 

  138. Ferlito A, Shaha AR, Silver CE, Rinaldo A, Mondin V. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec. 2001;63(4):202–7.

    PubMed  CAS  Google Scholar 

  139. Wax MK, Myers LL, Gabalski EC, Husain S, Gona JM, Nabi H. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer. Arch Otolaryngol Head Neck Surg. 2002;128(6):703–7.

    PubMed  Google Scholar 

  140. Perlow A, Bui C, Shreve P, Sundgren PC, Teknos TN, Mukherji SK. High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestive tract. J Comput Assist Tomogr. 2004;28(5):704–9.

    PubMed  Google Scholar 

  141. Teknos TN, Rosenthal EL, Lee D, Taylor R, Marn CS. Positron emission tomography in the evaluation of stage III and IV head and neck cancer. Head Neck. 2001;23(12):1056–60.

    PubMed  CAS  Google Scholar 

  142. van Veen SA, Balm AJ, Valdes Olmos RA, et al. Occult primary tumors of the head and neck: accuracy of thallium 201 single-photon emission computed tomography and computed tomography and/or magnetic resonance imaging. Arch Otolaryngol Head Neck Surg. 2001;127(4):406–11.

    PubMed  Google Scholar 

  143. Nguyen C, Shenouda G, Black MJ, Vuong T, Donath D, Yassa M. Metastatic squamous cell carcinoma to cervical lymph nodes from unknown primary mucosal sites. Head Neck. 1994;16(1):58–63.

    PubMed  CAS  Google Scholar 

  144. Maulard C, Housset M, Brunel P, et al. Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma. Laryngoscope. 1992;102(8):884–90.

    PubMed  CAS  Google Scholar 

  145. Harper CS, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. Cancer in neck nodes with unknown primary site: role of mucosal radiotherapy. Head Neck. 1990;12(6):463–9.

    PubMed  CAS  Google Scholar 

  146. Koch WM, Bhatti N, Williams MF, Eisele DW. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg. 2001;124(3):331–3.

    PubMed  CAS  Google Scholar 

  147. Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck. 1998;20(8):739–44.

    PubMed  CAS  Google Scholar 

  148. Miller FR, Hussey D, Beeram M, Eng T, McGuff HS, Otto RA. Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg. 2005;131(7):626–9.

    PubMed  Google Scholar 

  149. Davidson BJ, Spiro RH, Patel S, Patel K, Shah JP. Cervical metastases of occult origin: the impact of combined modality therapy. Am J Surg. 1994;168(5):395–9.

    PubMed  CAS  Google Scholar 

  150. Talmi YP, Wolf GT, Hazuka M, Krause CJ. Unknown primary of the head and neck. J Laryngol Otol. 1996;110(4):353–6.

    PubMed  CAS  Google Scholar 

  151. Nieder C, Gregoire V, Ang KK. Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? Int J Radiat Oncol Biol Phys. 2001;50(3):727–33.

    PubMed  CAS  Google Scholar 

  152. Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol. 2000;55(2):121–9.

    PubMed  CAS  Google Scholar 

  153. AAssar OS, Fischbein NJ, Caputo GR, et al. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology. 1999;210(1):177–81.

    PubMed  CAS  Google Scholar 

  154. Braams JW, Pruim J, Kole AC, et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg. 1997;26(2):112–5.

    PubMed  CAS  Google Scholar 

  155. Bohuslavizki KH, Klutmann S, Kroger S, et al. FDG PET detection of unknown primary tumors. J Nucl Med. 2000;41(5):816–22.

    PubMed  CAS  Google Scholar 

  156. Johansen J, Eigtved A, Buchwald C, Theilgaard SA, Hansen HS. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope. 2002;112(11):2009–14.

    PubMed  Google Scholar 

  157. Silva P, Hulse P, Sykes AJ, et al. Should FDG-PET scanning be routinely used for patients with an unknown head and neck squamous primary? J Laryngol Otol. 2007;121(2):149–53.

    PubMed  CAS  Google Scholar 

  158. Tepperman BS, Fitzpatrick PJ. Second respiratory and upper digestive tract cancers after oral cancer. Lancet. 1981;2(8246):547–9.

    PubMed  CAS  Google Scholar 

  159. Wax MK, Myers LL, Gona JM, Husain SS, Nabi HA. The role of positron emission tomography in the evaluation of the N-positive neck. Otolaryngol Head Neck Surg. 2003;129(3):163–7.

    PubMed  Google Scholar 

  160. Choi JY, Lee KS, Kwon OJ, et al. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol. 2005;23(30):7654–9.

    PubMed  Google Scholar 

  161. Kamel EM, Thumshirn M, Truninger K, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med. 2004;45(11):1804–10.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiology Department, University of Michigan, B2A209, UM11S, 1500 E. Med Ctr Dr., Ann Arbor, MI, 48109, USA

    Gaurang V. Shah

Authors
  1. Suyash Mohan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gaurang V. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gaurang V. Shah .

Editor information

Editors and Affiliations

  1. , Dept of Radio-Oncology, Genolier Swiss Medical Network, 4 Route du Muids, Genolier, CH-1272, Switzerland

    Jacques Bernier

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Mohan, S., Shah, G.V. (2011). Morphologic Investigations in Head and Neck Cancer. In: Bernier, J. (eds) Head and Neck Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9464-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9464-6_13

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-9463-9

  • Online ISBN: 978-1-4419-9464-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation